RA Capital Management - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$51,547,086
+34.5%
11,609,7040.0%1.02%
+40.4%
Q2 2023$38,312,023
+15.8%
11,609,7040.0%0.72%
-3.5%
Q1 2023$33,087,656
-52.2%
11,609,704
+22.1%
0.75%
-46.7%
Q4 2022$69,203,134
+22.2%
9,505,925
+35.8%
1.40%
+16.2%
Q3 2022$56,630,0007,000,0001.21%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$24,556,00011.69%
TRV GP III, LLC 5,962,202$62,484,00010.91%
ACUTA CAPITAL PARTNERS, LLC 604,074$6,331,0002.53%
COWEN AND COMPANY, LLC 1,319,887$13,832,0000.72%
Altium Capital Management LP 213,533$2,238,0000.52%
RTW INVESTMENTS, LP 3,205,291$33,591,0000.51%
Parkman Healthcare Partners LLC 146,389$1,534,0000.34%
Casdin Capital, LLC 1,154,476$12,099,0000.31%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,627,444$17,056,0000.26%
HARVARD MANAGEMENT CO INC 410,714$4,304,0000.25%
View complete list of FULCRUM THERAPEUTICS INC shareholders